期刊文献+

转染外源性PTEN基因人胃癌细胞生长情况及其对化疗药物敏感性的观察 被引量:2

Growth and susceptibility to chemical therapy drug of gastric carcinoma cell transfected oxogenous PTEN gene
下载PDF
导出
摘要 目的观察转染外源性PTEN基因人胃癌细胞的生长情况及其对化疗药物敏感性的影响。方法人胃癌BGC823细胞转染PEAK8空载质粒和PEAK8-PTEN质粒,稳定表达后予足叶乙甙和阿霉素干预;RT-PCR法检测PTEN mRNA表达,MTT法检测细胞生长活力,流式细胞术分析细胞周期。结果转染PEAK8-PTEN质粒的BGC823细胞PTEN mRNA强表达,明显高于转染空载质粒和未转染细胞;PTEN转染后肿瘤细胞存活率下降(P<0.05),联合化疗药细胞存活率更低(P<0.01);转染PTEN加两种化疗药处理后均出现G2/M为0,细胞阻断于S期。结论转染PTEN基因的人胃癌BGC823细胞生长受抑制,对化疗药敏感性增加。 Objective To observe the growth and susceptibility to chemical therapy drug of gastric carcinoma cell transfected exogenous PTEN gene. Methods PEAK8 and PEAK8-PTEN plasmid were transferred into gastric carcinoma cell line BGC823 . The stable expression cell line was interfered by etoposide and doxorubicin hydrochloride. The expression of target genes was detected by RT-PCR. Cell viability was determined by MTT assay. Cell cycle analysis was determined by flow cytometry. Results The expression of PTEN was verified in group transfected with PEAK8-PTEN plasmid, but not in PEAK8 group and the control group . The groups transfected with PTEN had much lower cell viability than corresponding ones( P 〈 0.05 ) , especially in PEAK8-PTEN group interfered by chemical drug meanwhile (P 〈 0.01 ) . PTEN genc transfection could block cell cycle before S stage. Conclusion PTEN gene transfection could suppress the growth of gastric carcinoma cell line BGC823 and enhance its susceptibility to chemical therapy drug in vitn.
作者 刘晋
机构地区 江汉大学医学院
出处 《山东医药》 CAS 北大核心 2009年第34期1-3,共3页 Shandong Medical Journal
关键词 胃肿瘤 第10号染色体同源丢失性磷酸酶-张力蛋白 基因转染 化学疗法 gastric carcinoma phosphatase and tensin homolog deleted on chromosome ten gene transfection chemical therapy
  • 相关文献

参考文献3

二级参考文献52

  • 1[1]Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH,Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R,Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362
  • 2[2]Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,Ittmarn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947
  • 3[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129
  • 4[4]Cantley LC, Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240-4245
  • 5[5]Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998; 95:15587-15591
  • 6[6]Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A 1999; 96:6199-6204
  • 7[7]Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases.Annu Rev Biochem 2001; 70: 247-279
  • 8[8]Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
  • 9[9]Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70:829-844
  • 10[10]Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 2001; 61:589-593

共引文献133

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部